Human Testing of Johnson & Johnson Coronavirus Vaccine to Begin By September. Johnson & Johnson said Monday that its experimental vaccine could be available for emergency use authorization by early 2021. The company said it has committed more than $1 billion to co-fund the vaccine research. with the federal Biomedical Advanced Research and Development Authority, part of the Department of Health and Human Services. Shares of Johnson & Johnson rose more than 4% in premarket trading following the announcement. Johnson & Johnson is also increasing its manufacturing capacity with a new location in the U.S.. and expansions to existing sites in other countries to potentially distribute the vaccine quickly. We have very good early indicators that not only can we depend on this to be a safe vaccine base but also one that will ultimately be effective, Alex Gorsky, Johnson & Johnson CEO, via CNBC. This is a bit of a moonshot for J&J going forward, but it’s one we feel is very, very important for use to be doing at this period in time, Alex Gorsky, via CNBC
Support local journalism
We are making critical coverage of the coronavirus available for free.
Please consider subscribing so we can continue to bring you the latest news and information on this developing story.
This Week's Circulars
- Anderson man dies of gunshot wounds
- LIVE UPDATES: Protesters march through downtown Anderson
- Anderson officials: Protest violence flared after midnight
- APD investigates shooting that left man in critical condition
- 'A really good man': Family grieves man's death in tree trimming accident
- Missing woman's hometown shows support
- More than 100 people protest police brutality across America in Anderson
- Two men charged in elaborate scam to fleece families of $28,000
- Inmate severs finger, sends it to THB with complaints about Madison County jail
- APD investigates reported self-inflicted stabbing